분류되지 않음 Archives - Cardio ThinkLab

Cardiometabolic Cardiovascular

홈 > 분류되지 않음

CTL-Dr-Genis_E

Peptide for Life initiative란 무엇입니까?

Dr Antoni Bayes-Genis

2 3월 2022

Q1. “Peptide for Life” initiative란 무엇입니까? 이 initiative의 주요 이해관계자는 누구입니까? Peptide for Life initiative는 유럽 전역에서 급성 심부전 진단 시 나트륨이뇨 펩티드 사용에 동등한 접근성을 제공하기 위한 액션 플랜입니다. 일관된 과학적 증거와 임상 지침의 가장 고등급 권장사항에 근거해, 지침...

Dr-Sim-Clinical-Cases-Cardio-ThinkLab

아시아에서의 심부전 – 현재의 문제와 미래의 전략

Dr David Sim

banner-template-FINAL.pptx

<img width="640" height="233" src="https://cardiothinklab.com/wp-content/uploads/2021/11/banner-template-FINAL.pptx-1024x373.jpg" class="attachment-large size-large wp-post-image" alt="banner-template-FINAL.pptx" decoding="async" srcset="https://cardiothinklab.com/wp-content/uploads/2021/11/banner-template-FINAL.pptx-1024x373.jpg 1024w, https://cardiothinklab.com/wp-content/uploads/2021/11/banner-template-FINAL.pptx-300x109.jpg 300w, https://cardiothinklab.com/wp-content/uploads/2021/11/banner-template-FINAL.pptx-768x280.jpg 768w, https://cardiothinklab.com/wp-content/uploads/2021/11/banner-template-FINAL.pptx-1536x560.jpg 1536w, https://cardiothinklab.com/wp-content/uploads/2021/11/banner-template-FINAL.pptx.jpg 1920w" sizes="(max-width: 640px) 100vw, 640px" />

임상 사례: 급성 심장 질환과 만성 심장 질환의 구별

<img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/07/Dr-Evangelos-Giannitsis-Cardio-ThinkLab-150x150.jpg" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://cardiothinklab.com/wp-content/uploads/2021/07/Dr-Evangelos-Giannitsis-Cardio-ThinkLab-150x150.jpg" width="150" height="150">

Dr Evangelos Giannitsis

banner-template-FINAL.pptx

<img width="640" height="233" src="https://cardiothinklab.com/wp-content/uploads/2021/11/banner-template-FINAL.pptx-1024x373.jpg" class="attachment-large size-large wp-post-image" alt="banner-template-FINAL.pptx" decoding="async" srcset="https://cardiothinklab.com/wp-content/uploads/2021/11/banner-template-FINAL.pptx-1024x373.jpg 1024w, https://cardiothinklab.com/wp-content/uploads/2021/11/banner-template-FINAL.pptx-300x109.jpg 300w, https://cardiothinklab.com/wp-content/uploads/2021/11/banner-template-FINAL.pptx-768x280.jpg 768w, https://cardiothinklab.com/wp-content/uploads/2021/11/banner-template-FINAL.pptx-1536x560.jpg 1536w, https://cardiothinklab.com/wp-content/uploads/2021/11/banner-template-FINAL.pptx.jpg 1920w" sizes="(max-width: 640px) 100vw, 640px" />

임상 사례: hs-cTnT 상승의 진단 관련성

<img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/07/Dr-Evangelos-Giannitsis-Cardio-ThinkLab-150x150.jpg" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://cardiothinklab.com/wp-content/uploads/2021/07/Dr-Evangelos-Giannitsis-Cardio-ThinkLab-150x150.jpg" width="150" height="150">

Dr Evangelos Giannitsis

FA-CardioThinkLab_Banner_ProfCho_Outline-scaled

한국의 임상 사례: 심근병증에서의 NT-proBNP 수치

Dr. 조동혁

Cardio-ThinkLab-clinical-cases-3

임상 사례: 비심장 질환에서 hs-TnT 상승

<img width="150" height="150" data-src="https://cardiothinklab.com/wp-content/uploads/2021/07/Dr-Evangelos-Giannitsis-Cardio-ThinkLab-150x150.jpg" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://cardiothinklab.com/wp-content/uploads/2021/07/Dr-Evangelos-Giannitsis-Cardio-ThinkLab-150x150.jpg" width="150" height="150">

Dr Evangelos Giannitsis

Dr-Lee-Clinical-Cases-Cardio-ThinkLab-2

Dr Lee의 임상 사례: hs-TnT의 AMI 조기 진단

<img src="https://cardiothinklab.com/wp-content/uploads/2021/02/Dr-Chien-Chang-Lee--150x150.jpg" width="150" height="150">

Dr Lee Chien-Chang

Cardio-ThinkLab-Role-of-NT-proBNP-in-Heart-Failure-Management

FAQ: 심부전 관리에서 NT-proBNP의 역할

Dr James L Januzzi, Dr David Sim

Cardio-ThinkLab-webinar-ACS

ED에서 급성 관상동맥 증후군 관리의 최전선

<img src="https://cardiothinklab.com/wp-content/uploads/2021/02/Dr-Chien-Chang-Lee--150x150.jpg" width="150" height="150">

Dr Lee Chien-Chang, Dr Cynthia Papendick

Benefits-of-0h-1h-Algorithm-to-Patients-in-Asia

아시아 환자들에서 0h/1h 알고리즘의 이점

Dr Masayuki Shiozaki, Dr. Suguru Asako, +2 more

webinar-banner-no-face-2

심부전에서의 나트륨이뇨 펩티드 사용에 대한 최신 IFCC 권장사항 – 분석 및 임상적 고려사항

Prof. Peter Kavsak, Dr Carolyn Lam

webinar

AF에서 새로운 바이오마커 기반 위험 점수: ABC 위험 점수

Dr Ching Chi Keong, Dr Lars Wallentin

Load more articles

2800 이상의 의료 전문가들이 Cardiac insight가 담긴 뉴스레터를 구독하고 있습니다.

가입하셔서 이메일을 통해 최신 업데이트를 받으세요